MAGNETIC MICROCLUSTERS FOR MRI CONTRAST AGENTS

Information

  • Research Project
  • 3492939
  • ApplicationId
    3492939
  • Core Project Number
    R43CA056146
  • Full Project Number
    1R43CA056146-01A1
  • Serial Number
    56146
  • FOA Number
  • Sub Project Id
  • Project Start Date
    4/20/1992 - 32 years ago
  • Project End Date
    7/31/1992 - 32 years ago
  • Program Officer Name
  • Budget Start Date
    4/20/1992 - 32 years ago
  • Budget End Date
    7/31/1992 - 32 years ago
  • Fiscal Year
    1992
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    4/17/1992 - 32 years ago
Organizations

MAGNETIC MICROCLUSTERS FOR MRI CONTRAST AGENTS

A novel class of material has been discovered that exhibits non-magnetic behavior in its native (sub 50A) state, but when assembled into clusters of above 500A in diameter exhibits superparamagnetic behavior. Materials of this type can be prepared as biodegradable 500A clusters, injected into patients and used as safe, non-toxic, degradable MRI contrast agents. A research program is proposed to utilize these magnetic clusters as agents for MRI contrast, to build clusters of various sizes for size exclusion delivery to specific organs for contrasting in MRI and to study the 60Hz and RP magnetic field response of these clusters vs. cluster size, time, pH and temperature. Omni Quest acknowledges the need for in vivo testing to determine the viability of its research and while such a program is not feasible within the limits of a Phase I proposal by a "small business", a biological analysis of candidate materials will be conducted and a strategic plan for accomplishing in vivo testing is in place. Based upon a successful Phase I, Omni Quest has already entered into research collaboration agreements with significant international pharmaceutical companies and research centers that have the ability and intent to conduct in vivo testing in animals. These confidential relationships will be disclosed within the protected portion of this proposal only.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R43
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    394
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    SSS
  • Study Section Name
  • Organization Name
    BIOQUEST, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    ATKINSON
  • Organization State
    NH
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    03811
  • Organization District
    UNITED STATES